Screener
ImmunityBio, Inc. IBRX Gains (losses) - FVO: changes in fair value
Gains (losses) - FVO: changes in fair value at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FairValueOptionChangesInFairValueGainLoss1.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | $(632,797) | $(129,666) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Change in fair value of warrant liabilities | 295,413 | 448 |
| Change in fair value of related-party convertible note | 236,625 | 42,582 |
| Non-cash interest expense related to revenue interest liability | 8,317 | 13,266 |
| Stock-based compensation expense | 8,169 | 9,537 |
| Write-off of convertible note receivable | 7,442 | — |
| Depreciation and amortization | 4,380 | 3,829 |
ITEM 1. FINANCIAL STATEMENTS.
FAQ
- What is ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value?
- ImmunityBio, Inc. (IBRX) reported gains (losses) - FVO: changes in fair value of -$236.63M in Q1 2026.
- How has ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value changed year-over-year?
- ImmunityBio, Inc.'s gains (losses) - FVO: changes in fair value decreased by 455.7% year-over-year, from -$42.58M to -$236.63M.
- What does gains (losses) - FVO: changes in fair value mean?
- This metric reflects the non-cash gains or losses resulting from the company's election to measure certain financial instruments at fair value. It captures the impact of market price changes on these specific assets or liabilities on the income statement.
Ask your AI about ImmunityBio, Inc.'s gains (losses) - fvo: changes in fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude